くすりのしおり

Injection
Revised: 12/2020

The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.
Brand name :
Modacin for Injection 0.5g
 Active ingredient:
Ceftazidime hydrate
 Dosage form:
injection
 Print on wrapping:

Effects of this medicine

This medicine is a cephem antibiotic and shows antibacterial action by inhibiting synthesis of bacterial cell wall.
It is usually used to treat a wide range of bacterial infections.

Before using this medicine, be sure to tell your doctor and pharmacist

  • If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
    If you have renal disorder.
  • If you are pregnant or breastfeeding.
  • If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)

Dosing schedule (How to take this medicine)

  • Your dosing schedule prescribed by your doctor is ((        to be written by a healthcare professional))
  • In general, inject this medicine intravenously twice a day for adults, 2 to 4 times a day for children, 2 to 3 times a day for 0 to 3 days old premature infant/newborn infant, and 3 to 4 times a day for 4 days old or older premature infant/newborn infant. Alternatively this medicine may also be injected with an intravenous drip infusion.
    For refractory or severe infection, inject this medicine intravenously 2 to 4 times a day, regardless of age and according to the symptoms.
  • Ask the doctor about the treatment span.

Precautions while taking this medicine

Possible adverse reactions to this medicine

The most commonly reported adverse reactions include abnormal liver function, rash, itch, fever, diarrhea, hives and erythema. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
  • discomfort, intraoral abnormal feeling, wheezing [shock, anaphylaxis]
  • decreased urine output, general edema [serious renal disorder such as acute renal disorder]
  • anemic symptoms, fever, bleeding tendency [hematologic disorder such as pancytopenia]
  • abdominal pain, frequent diarrhea, fever [serious colitis accompanied by bloody stool such as colitis pseudomembranous]
  • fever, erythema/blister/erosion, congested bulbar conjunctiva [toxic epidermal necrolysis, muco-cutaneo-ocular syndrome]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.

Storage conditions and other information

For healthcare professional use only : Day Month Year

For further information, talk to your doctor or pharmacist.